Product Categories
Country: | United States |
---|---|
Tel: | |
Mobile: | 6314854226 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Olanzapine Impurity 25 | C6H6N2 | 52833-34-8 | Details |
Mirabegron impurity 003 | C8H7FN2O3 | 1018983-85-1 | Details |
Vonoprazan Impurity 24 | C17H14FN3O3S | 1883595-39-8 | Details |
Linezolid Impurity 42 | C3H8ClNO | 725676-93-7 | Details |
Rosuvastatin Impurity 12 | C25H32FN3O6S | 894787-93-0 | Details |
Olmesartan Impurity 13 | C14H11BrN4 | 138402-33-2 | Details |
Sodium 2-((2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl)acetate | C13H15N2NaO4 | 136983-81-8 | Details |
2-Chloro Vonoprazan | C17H15ClFN3O2S | 928325-68-2 | Details |
Linezolid Impurity 44 | C5H9NO2 | 183805-10-9 | Details |
Mirabegron impurity 002 | C10H11NO2 | 81259-56-5 | Details |
1-Methyl-4-sulfopyridinium Hydroxide Inner Salt | C6H7NO3S | 4416-69-7 | Details |
p-[N-(p-Fluorophenyl)formimidoyl]phenol | C13H10FNO | 3382-63-6 | Details |
Febuxostat Impurity 23 | C15H13NO5S | 2073891-59-3 | Details |
Tetrabutylammonium periodate | C16H36INO4 | 65201-77-6 | Details |
Pendimethalin | C13H19N3O4 | 40487-42-1 | Details |
Cefazolin Impurity D | C13H14N6O6S | 32510-61-5 | Details |
endo-BCN-PEG4-NHS ester | 1807501-86-5 | Details |
Celecoxib Related Compound B | C17H14F3N3O2S | 331943-04-5 | Details |
Resiquimod-[d5] | C17H22N4O2 | 2252319-44-9 | Details |
Celecoxib Impurity A | C17H14F3N3O2S | 170570-01-1 | Details |
Rifamycin S | C37H45NO12 | 13553-79-2 | Details |
PF-04457845 | C23H20F3N5O2 | 1020315-31-4 | Details |
Proteinase K | C29H27N2O12P | 39450-01-6 | Details |
GYY-4137 Morpholine salt | C15H25N2O3PS2 | 106740-09-4 | Details |
6-Ethynyl-4,4-Dimethyl Thiochroman | C13H14S | 118292-06-1 | Details |
N'-(5-Chloropyridin-2-yl)-N-[(1R,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide | C24H30ClN7O4S | 1255529-24-8 | Details |
Cefazolin EP Impurity G | C11H10N6O4S | 1172998-53-6 | Details |
Atorvastatin EP Impurity C | C33H36CaF2N2O5 | 693793-53-2 | Details |
1-methylpyridin-1-ium-2-carboxamide iodide | 3861-69-6 | Details |
Terazosin EP Impurity E | C24H28N8O4 | 102839-00-9 | Details |
1-methylpyridin-1-ium-2-carboxamide chloride | 21032-31-5 | Details |
6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine hydrochloride | C14H20ClN5O2 | 70843-11-7 | Details |
Terazosin Related Compound A | C19H25N5O4 | 60548-08-5 | Details |
Dapoxetine Impurity 1 | C19H16O | 94305-25-6 | Details |
3-(4-(3-hydroxy-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one | C28H26O3 | 2242008-36-0 | Details |
Nifuratel Impurity 6 | C5H10N2O2S | 25517-72-0 | Details |
(R)-Terazosin | C19H25N5O4 | 109351-34-0 | Details |
Nifuratel Impurity 4 | C9H9N3O6 | 41359-15-3 | Details |
Terbutaline Impurity 6 hydrobromide | C26H30BrNO3 | 28924-20-1 | Details |
Dapoxetine Impurity 2 | C30H31NO2 | 2242008-37-1 | Details |
1-(1-phenylethyl)imidazole | C11H12N2 | 60197-34-4 | Details |
Dapoxetine Impurity 8 | C30H31NO | 2245197-07-1 | Details |
Palbociclib Impurity 10 | C41H55N11O5 | 2206135-30-8 | Details |
Palbociclib Impurity 2 | C24H29N7O | 2204863-06-7 | Details |
Palbociclib Impurity 022 | C14H20N4O4 | 1779124-68-3 | Details |
Palbociclib Impurity 025 | C25H29N7O3 | 2174002-16-3 | Details |
Palbociclib Impurity F | C14H22N4O2 | 1023594-49-1 | Details |
tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | C29H37N7O3 | 1941177-45-2 | Details |
Valdecoxib Impurity I | C16H15N3O5S2 | 1373038-59-5 | Details |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetamide | C18H16N2O4S | 198471-06-6 | Details |
Valdecoxib Impurity B | C32H25N3O6S2 | 1373038-60-8 | Details |
Palbociclib Impurity 030 | C9H12N4O2 | 1211541-02-4 | Details |
Parecoxib Impurity 1 | C22H23N3O7S2 | 1708094-99-8 | Details |
methyl 1-(2-chloroacetyl)-2-oxo-3H-indole-6-carboxylate | C12H10ClNO4 | 1160293-25-3 | Details |
Palbociclib Impurity 029 | C9H12N4O2 | 1566082-34-5 | Details |
Lisinopril Impurity F | C21H37N3O5 | 1132650-67-9 | Details |
Terazosin EP Impurity O | C14H22N2O4 | 547730-06-3 | Details |
1-Piperazinyl[(2R)-tetrahydro-2-furanyl]methanone | C9H16N2O2 | 412334-56-6 | Details |
Dapoxetine Impurity 2 hydrochloride | C30H32ClNO2 | 2242008-38-2 | Details |
Terbutaline Impurity 22 | C22H20O4 | 1226543-90-3 | Details |
Esmolol Impurity 1 | C13H16O4 | 81147-94-6 | Details |
3-(4-hydroxynaphthalen-1-yl)-1-phenylpropan-1-one | C19H16O2 | 126113-24-4 | Details |
Etomidate Impurity 1 | C11H12N2 | 844658-92-0 | Details |
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethan-1-one sulfate | C33H35NO3.H2O4S | 882066-15-1 | Details |
N-Tert-Butyldibenzylamine | C18H23N | 30923-82-1 | Details |
Nifuratel Impurity 2 | C10H11N3O6S | 1445990-09-9 | Details |
Dapoxetine Impurity 24 | C19H18O2 | 908291-72-5 | Details |
tert-butyl 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carboxylate | C19H27N5O4 | 1260939-66-9 | Details |
Dabigatran Impurity 20 | C33H38N6O6 | 1408238-39-0 | Details |
Paroxetine Mesylate | C20H24FNO6S | 217797-14-3 | Details |
(2S)-Isopropyl 2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate | C18H17F5NO5P | 1256490-52-4 | Details |
Valdecoxib Impurity E | C16H11Cl2NO5S2 | 1373038-63-1 | Details |
Hydroxy Ivabradine | C15H21NO4 | 1235547-07-5 | Details |
3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole | C11H9F3N2 | 219986-64-8 | Details |
Parecoxib Impurity 24 | C20H20N2O4S | 198470-82-5 | Details |
Leucosceptoside A | C30H38O15 | 83529-62-8 | Details |
Dacarbazine | C6H10N6O | 4342-03-4 | Details |
19-Hydroxy-10-deacetyl baccatin-III | C29H36O11 | 154083-99-5 | Details |
Fomesafen | C15H10ClF3N2O6S | 72178-02-0 | Details |
Deoxyandrographolide | C20H30O4 | 79233-15-1 | Details |
Mogrol | C30H52O4 | 88930-15-8 | Details |
Nα,Nα-Bis-Fmoc-L-cystine bis(tert-butyl ester) | C44H48N2O8S2 | 139592-37-3 | Details |
Ethyl 2-bromothiophene-3-carboxylate | C7H7BrO2S | 632325-50-9 | Details |
Posaconazole Diastereoisomer Related Compound 2 | C21H21F2N3O4S | 166583-12-6 | Details |
15(S)-Latanoprost | C26H40O5 | 145773-22-4 | Details |
Pantoprazole EP Impurity E | C32H28F4N6O8S2 | 2115779-15-0 | Details |
Triethylene Glycol Mono(2-propynyl) Ether | C9H16O4 | 208827-90-1 | Details |
Chrysin-7-O-glucoronide | C21H18O10 | 35775-49-6 | Details |
Monodes(N-carboxymethyl)valine Daclatasvir | C33H39N7O3 | 1007884-60-7 | Details |
DOTA-NOC | C69H92N14O18S2 | 619300-53-7 | Details |
Ethyl 5-bromothieno[3,2-b]thiophene-6-carboxylate | C9H7BrO2S2 | 2055722-78-4 | Details |
Dapagliflozin Impurity 3 | C21H25BrO6 | 1807632-95-6 | Details |
Ingenol-5,20-acetonide | C23H32O5 | 77573-43-4 | Details |
MCP110 | C33H36N2O3 | 521310-51-0 | Details |
(3R,5R)-Rosuvastatin Calcium | C22H30CaFN3O6S | 1422515-55-6 | Details |
Heptakis(6-deoxy-6-thio)-beta-cyclodextrin | C42H70O28S7 | 160661-60-9 | Details |
Cy5-NHS ester | C37H43N3O10S2 | 146368-14-1 | Details |
Semax | C37H51N9O10S | 80714-61-0 | Details |
(3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
Polyadenosinic acid potassium salt | C10H13KN5O7P | 26763-19-9 | Details |
Product Total: Product Page: | ||||
35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 |